[Treatment of abdominal aortic aneurysm by application of a Corvita endoprosthesis. Medium-term results of a feasibility study].
Despite improvements in surgical techniques, progress in anesthesia and hemodynamic control, the risk of fatal outcome in the standard surgical technique for aneurysms of the abdominal aorta remains at about 5 to 6% due to associated coronary and pulmonary lesions. Surgical access to the aneurysm may also be hindered in patients with a past history of multiple abdominal operations. In collaboration with the Corvita company, we developed a modular endoprosthesis for endoluminal treatment of AAA and report the results of a feasibility study.
Dereume
J P
JP
Service de Pathologie vasculaire, hôpital Erasme, Bruxelles, Belgique.
Ferreira
J
J
Dehon
P
P
Cavenaile
J C
JC
Le Minh
T
T
Motte
S
S
Guyot
S
S
Wautrecht
J C
JC
D017544:Aortic Aneurysm, Abdominal / Q000601:surgery*; D005240:Feasibility Studies; D006801:Humans; D011183:Postoperative Complications; D015607:Stents; D013997:Time Factors
Traitement de l'anévrisme de l'aorte abdominale par application d'une endoprothèse Corvita. Résultats à moyen terme d'une étude de faisabilité.